. Author manuscript; available in PMC: 2020 Sep 28.

Published in final edited form as: Sci Transl Med. 2020 Jan 15;12(526):eaax6249. doi: 10.1126/scitranslmed.aax6249

Table 2.

Demographic information of recipients and the corresponding matched donors in relation to engraftment of donor-derived mutations.

Characteristic	Category	No donor mutation (n = 14)	Mutation engrafted (n = 11)	P	Test performed
Donor age	Median (range)	24 (21 to 39)	36 (20 to 58)	0.03	Wilcoxon rank-sum test
Donor gender	Male	10 (71.4%)	8 (72.7%)	0.99	Fisher’s exact test
Donor gender	Female	4 (28.6%)	3 (27.3%)	0.99	Fisher’s exact test
Recipient age	Median (range)	51 (27 to 65)	55 (19 to 69)	0.66	Wilcoxon rank-sum test
Recipient gender	Male	13 (92.9%)	7 (63.6%)	0.13	Fisher’s exact test
Recipient gender	Female	1 (7.1%)	4 (36.4%)	0.13	Fisher’s exact test
Primary disease	AML/MDS	7 (50%)	9 (81.8%)	0.21	Fisher’s exact test
Primary disease	Non-AML	7 (50%)	2 (18.2%)	0.21	Fisher’s exact test
Disease status prior to transplant	CR	7 (50%)	5 (45.4%)
	Non-CR	7 (50%)	5 (45.4%)	0.99	Fisher’s exact test
	Unknown	0 (0%)	1 (9.1%)
Conditioning	MAC	8 (57.1%)	7 (63.6%)	0.99	Fisher’s exact test
Conditioning	Non-MAC	6 (42.9%)	4 (36.4%)	0.99	Fisher’s exact test
HLA mismatch	No mismatch	13 (92.9%)	9 (81.8%)	0.56	Fisher’s exact test
HLA mismatch	Mismatch	1 (7.1%)	2 (18.2%)	0.56	Fisher’s exact test

CR, complete remission; MAC, myeloablative conditioning.